Matthew Plavan
2017 - Arcadia Biosciences
In 2017, Matthew Plavan earned a total compensation of $484.7K as Chief Financial Officer at Arcadia Biosciences, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $95,844 |
|---|---|
| Option Awards | $108,853 |
| Salary | $280,010 |
| Total | $484,707 |
Plavan received $280K in salary, accounting for 58% of the total pay in 2017.
Plavan also received $95.8K in non-equity incentive plan and $108.9K in option awards.
Rankings
In 2017, Matthew Plavan's compensation ranked 11,993rd out of 14,666 executives tracked by ExecPay. In other words, Plavan earned more than 18.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,993 out of 14,666 | 18th |
Division Agriculture, Forestry, And Fishing | 28 out of 50 | 44th |
Major group Agricultural Production Crops | 17 out of 30 | 43rd |
Source: SEC filing on May 17, 2018.
Plavan's colleagues
We found two more compensation records of executives who worked with Matthew Plavan at Arcadia Biosciences in 2017.
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019